Cargando…

Menopause-associated risk of cardiovascular disease

Cardiovascular disease (CVD) is of major concern in women entering menopause. The changing hormonal milieu predisposes them to increased CVD risk, due to a constellation of risk factors, such as visceral obesity, atherogenic dyslipidemia, dysregulation in glucose homeostasis, non-alcoholic fatty liv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anagnostis, Panagiotis, Lambrinoudaki, Irene, Stevenson, John C, Goulis, Dimitrios G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066596/ https://www.ncbi.nlm.nih.gov/pubmed/35258483 http://dx.doi.org/10.1530/EC-21-0537

Ejemplares similares

Vitamin D, Menopausal Health and COVID-19: Critical Appraisal of Current Data
por: Anagnostis, Panagiotis, et al.
Publicado: (2023)

Bone Health in Patients with Dyslipidemias: An Underestimated Aspect
por: Anagnostis, Panagiotis, et al.
Publicado: (2022)

Diet and lifestyle for post-reproductive health: Focus on diabetes
por: Paschou, Stavroula Α., et al.
Publicado: (2018)

Menopausal hormone therapy for women with obesity in the era of COVID-19
por: Paschou, Stavroula A., et al.
Publicado: (2020)

Menopause, androgens, and cardiovascular ageing: a narrative review
por: Armeni, Eleni, et al.
Publicado: (2022)

“Holidays” for osteoporosis drugs: A case-based approach
por: Anagnostis, Panagiotis, et al.
Publicado: (2019)

Menopausal hormone therapy and breast cancer risk: All progestogens are not the same
por: Lambrinoudaki, Irene
Publicado: (2020)

The Impact of Obesity on the Association between Vitamin D Deficiency and Cardiovascular Disease
por: Paschou, Stavroula A., et al.
Publicado: (2019)

Vitamin D and Obesity: Two Interacting Players in the Field of Infertility
por: Bosdou, Julia K., et al.
Publicado: (2019)

Early menopause and cardiovascular risk factors: a cross-sectional and longitudinal study
por: Roa-Díaz, Zayne Milena, et al.
Publicado: (2023)

Starting and stopping menopausal hormone therapy and antidepressants for hot flushes: A case-based approach
por: Athanasiadis, Loukas, et al.
Publicado: (2019)

Risk of gestational diabetes mellitus in women achieving singleton pregnancy spontaneously or after ART: a systematic review and meta-analysis
por: Bosdou, Julia K, et al.
Publicado: (2020)

Screening and management of major endocrinopathies during pregnancy: an update
por: Paschou, Stavroula A., et al.
Publicado: (2022)

Association of menopausal symptoms with sociodemographic factors and personality traits
por: Augoulea, Areti, et al.
Publicado: (2020)

Previous Gestational Diabetes Mellitus and Markers of Cardiovascular Risk
por: Vrachnis, Nikolaos, et al.
Publicado: (2012)

Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists
por: Maas, Angela H E M, et al.
Publicado: (2021)

Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause
por: Miller, Virginia M, et al.
Publicado: (2013)

Menopause and Cardiovascular Disease
por: Mahajan, Annil, et al.
Publicado: (2019)

OR17-07 Retinol Binding Protein 4 Predicts Functional Vascular Disease in Early Postmenopausal Women
por: Armeni, Eleni, et al.
Publicado: (2020)

Adrenal hyperandrogenism does not deteriorate insulin resistance and lipid profile in women with PCOS
por: Paschou, Stavroula A, et al.
Publicado: (2017)

Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: risks, benefits, and current guidelines for use
por: Prabakaran, Sindhu, et al.
Publicado: (2021)

Menopause Predisposes Women to Increased Risk of Cardiovascular Disease
por: Kamińska, Magdalena Sylwia, et al.
Publicado: (2023)

The Major Impact of Obesity on the Development of Type 2 Diabetes (T2D) in Women With PCOS: A Systematic Review and Meta-Analysis of Observational Studies
por: Anagnostis, Panagiotis, et al.
Publicado: (2021)

SAT380 Clinical, Metabolic And Hormonal Profile In Women Carrying Cyp21a2 Mutations
por: Livadas, Sarantis, et al.
Publicado: (2023)

Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN
por: Thurston, Rebecca C., et al.
Publicado: (2021)

Menopausal Symptoms and Cardiovascular Disease Risk Indices Among Women With HIV
por: Toribio, Mabel, et al.
Publicado: (2021)

Assessment of Cardiovascular Risk in Natural and Surgical Menopause
por: Abbas, S. Zafar, et al.
Publicado: (2018)

Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
por: Rozenberg, S., et al.
Publicado: (2020)

Cardiovascular Changes in Menopause
por: Nair, Anjana R., et al.
Publicado: (2021)

Metabolic syndrome in the Mediterranean region: Current status
por: Anagnostis, Panagiotis
Publicado: (2012)

Fatty Acid Oxidation and Cardiovascular Risk during Menopause: A Mitochondrial Connection?
por: Oliveira, Paulo J., et al.
Publicado: (2012)

Combined effect of menopause and cardiovascular risk factors on death and cardiovascular disease: a cohort study
por: Li, Yan, et al.
Publicado: (2021)

Hormone therapy for first-line management of menopausal symptoms: Practical recommendations
por: Palacios, Santiago, et al.
Publicado: (2019)

Sexual Health in Menopause
por: Scavello, Irene, et al.
Publicado: (2019)

Meta-analysis: Early Age at Natural Menopause and Risk for All-Cause and Cardiovascular Mortality
por: Huan, Luyao, et al.
Publicado: (2021)

Duration of Reproductive Life Span, Age at Menarche, and Age at Menopause Are Associated With Risk of Cardiovascular Disease in Women
por: Ley, Sylvia H., et al.
Publicado: (2017)

Association of Vasomotor and Other Menopausal Symptoms with Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis
por: Muka, Taulant, et al.
Publicado: (2016)

Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?
por: Fonseca, Marília Izar Helfenstein, et al.
Publicado: (2017)

Protein Biomarkers of Early Menopause and Incident Cardiovascular Disease
por: Ramirez, Mariana F., et al.
Publicado: (2023)

Progestogens as a component of menopausal hormone therapy: the right molecule makes the difference
por: Stevenson, John C, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hq7a0npsqboct4q6m8r02jfuo5